文献
J-GLOBAL ID:201902247652389287
整理番号:19A0771756
REVERCE:既治療の転移性結腸直腸癌患者に対するレゴラフェニブ後のセツキシマブ対その逆の順序の無作為化第II相試験
REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients
著者 (18件):
SHITARA K.
(National Cancer Center Hospital East, Kashiwa)
,
YAMANAKA T.
(Yokohama City Univ. School of Medicine, Yokohama)
,
DENDA T.
(Chiba Cancer Center, Chiba)
,
TSUJI Y.
(Tonan Hospital, Sapporo)
,
SHINOZAKI K.
(Hiroshima Prefectural Hospital, Hiroshima)
,
KOMATSU Y.
(Hokkaido Univ. Hospital Cancer Center, Sapporo)
,
KOBAYASHI Y.
(Kushiro Rosai Hospital, Kushiro)
,
FURUSE J.
(Kyorin Univ. Fac. of Medicine, Tokyo)
,
OKUDA H.
(Keiyukai Sapporo Hospital, Sapporo)
,
ASAYAMA M.
(Saitama Cancer Center, Saitama)
,
AKIYOSHI K.
(Osaka City General Hospital, Osaka)
,
KAGAWA Y.
(Kansai Rosa Hospital, Amagasaki)
,
KATO T.
(National Hospital Organization Osaka National Hospital, Osaka)
,
OKI E.
(Kyushu Univ., Fukuoka)
,
ANDO T.
(Univ. Tsukuba, Tsukuba)
,
HAGIWARA Y.
(Univ. Tokyo, Tokyo)
,
OHASHI Y.
(Chuo Univ., Tokyo)
,
YOSHINO T.
(National Cancer Center Hospital East, Kashiwa)
資料名:
Annals of Oncology
(Annals of Oncology)
巻:
30
号:
2
ページ:
259-265
発行年:
2019年02月
JST資料番号:
W0107A
ISSN:
0923-7534
CODEN:
ANONE2
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)